Copper(I) 2-hydroxy-3-methylbenzoate

Catalog No.: 
ACRIMG573
CAS No.: 
326477-70-7
Molecular Formula: 
C8H7CuO3
Molecular Weight: 
214.69
Copper(I) 2-hydroxy-3-methylbenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$51.00In stockInquiry
10g95%$90.00In stockInquiry
25g95%$183.00In stockInquiry
100g95%$532.00In stockInquiry
500g95%$2179.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCopper(I) 2-hydroxy-3-methylbenzoate
IUPAC Namecopper(I) 2-hydroxy-3-methylbenzoate
MDL No.MFCD10699180
Molecular FormulaC8H7CuO3
Molecular Weight214.69
SMILESO=C([O-])C1=CC=CC(C)=C1O.[Cu+]
InChI KeyCPPQOSMKJDPRID-UHFFFAOYSA-M
SynonymCopper(I) 3-methylsalicylate;[2-(Hydroxy-κO)-3-methylbenzoato-κO]copper;CuMeSal;Copper(I) 2-hydroxy-3-methylbenzoate;2-carboxy-6-methylphenolate:copper(1+);SKL064;Copper, [2-(hydroxy-κO)-3-methylbenzoato-κO]-;2-carboxy-6-methylphenolate
CAS No.326477-70-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRIMG573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMNXI987 route compound structure diagram
    ACMNXI98726507-91-5In Stock
  2. Then
  3. ACRIMG573 route product structure diagram
    ACRIMG573326477-70-7In Stock
Inquiry

2. ACRIMG573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDS413 route compound structure diagram
    ACJMDS41332768-20-0In Stock
  2. Then
  3. ACRIMG573 route product structure diagram
    ACRIMG573326477-70-7In Stock
Inquiry

3. ACRIMG573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMNXI987 route compound structure diagram
    ACMNXI98726507-91-5In Stock
  2. Then
  3. ACRIMG573 route product structure diagram
    ACRIMG573326477-70-7In Stock
Inquiry

Comments (0)